Search alternatives:
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
de decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
2 de » 2 d (Expand Search), _ de (Expand Search), i de (Expand Search)
-
741
-
742
-
743
-
744
Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to halofantrine (HFN) and related antimalarials.
Published 2011“…Overexpression of <i>PF10_0355</i> decreases parasite susceptibility to (A) HFN and structurally related (B) mefloquine (MFQ) and (C) lumefantrine (LUM). …”
-
745
-
746
-
747
-
748
-
749
-
750
Decreased surface expression of megalin in cystinosin-deficient cells.
Published 2015“…Cystinotic cells demonstrated a decreased surface expression of multiligand receptors (** p<0.01). …”
-
751
Schematic representation of possible mechanism of action of OKN-007 in IC3752 pGBM tumor bearing mice.
Published 2015“…Dependent on the HSPG core protein, HSPGs are found at the cell surface (1), in the extracellular matrix (2), or in secretory vesicles [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0134276#pone.0134276.ref098" target="_blank">98</a>]. …”
-
752
-
753
-
754
-
755
-
756
-
757
Study selection criteria.
Published 2025“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”
-
758
PICOS criteria for the SLR.
Published 2025“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”
-
759
PRISMA flow chart.
Published 2025“…Durability was observed in a long-term follow-up trial (mean duration, 45.4 months) with a 0.9-point CAPS decrease from post-treatment.…”
-
760